NovoCure Limited (NVCR) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
NovoCure Limited (NVCR) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$220.71 MLiabilities$457.10 MNon-current liabilities$236.39 MCurrent assets$638.52 MEquity$338.09 MAssets$795.19 MGross equity(calculated)$1.72 BNon-current assets$156.67 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term investmentsTrade receivables, netCash and cash equivalentsReceivables and prepaid expensesInventoriesRestricted cashProperty and equipment, netRight-of-use assetsField equipment, netOther long-term assetsTrade payablesOther payables, lease liabilities and accrued expensesSenior secured credit facility, netLong-term leasesEmployee benefit liabilitiesAdditional paid-in capitalCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Retained earnings (accumulated deficit)Accumulated other comprehensive income (loss)Current liabilitiesCurrent liabilities$220.71 MTrade payablesTrade payables$130.73 MLiabilitiesLiabilities$457.10 MOther payables, lease liabilities and accrued expensesOther payables, lease liabilities and accrued expenses$89.98 MSenior secured credit facility, netSenior secured credit facility, net$195.89 MNon-current liabilitiesNon-current liabilities$236.39 MLong-term leasesLong-term leases$37.53 MCurrent assetsCurrent assets$638.52 MEmployee benefit liabilitiesEmployee benefit liabilities$2.97 MEquityEquity$338.09 MShort-term investmentsShort-term investments$346.86 MAssetsAssets$795.19 MGross equity (calculated)Gross equity(calculated)$1.72 BTrade receivables, netTrade receivables, net$99.13 MCash and cash equivalentsCash and cash equivalents$93.70 MReceivables and prepaid expensesReceivables and prepaid expenses$46.69 MInventoriesInventories$42.22 MRestricted cashRestricted cash$9.92 MProperty and equipment, netProperty and equipment, net$75.37 MNon-current assetsNon-current assets$156.67 MRight-of-use assetsRight-of-use assets$43.79 MField equipment, netField equipment, net$26.58 MAdditional paid-in capitalAdditional paid-in capital$1.72 BOther long-term assetsOther long-term assets$10.93 MRetained earnings (accumulated deficit)Retained earnings (accumulated deficit)−$1.38 BAccumulated other comprehensive income (loss)Accumulated other comprehensive income (loss)−$3.42 M
Chart details

NovoCure Limited (NVCR) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
795,191,000 US dollars
Current assets
638,521,000 US dollars
Non-current assets
156,670,000 US dollars
Liabilities
457,099,000 US dollars
Current liabilities
220,710,000 US dollars
Non-current liabilities
236,389,000 US dollars
Equity
338,092,000 US dollars
Short-term investments
346,858,000 US dollars
Trade receivables, net
99,131,000 US dollars
Cash and cash equivalents
93,701,000 US dollars
Receivables and prepaid expenses
46,690,000 US dollars
Inventories
42,224,000 US dollars
Restricted cash
9,917,000 US dollars
Property and equipment, net
75,369,000 US dollars
Right-of-use assets
43,789,000 US dollars
Field equipment, net
26,582,000 US dollars
Other long-term assets
10,930,000 US dollars
Trade payables
130,729,000 US dollars
Other payables, lease liabilities and accrued expenses
89,981,000 US dollars
Senior secured credit facility, net
195,891,000 US dollars
Long-term leases
37,529,000 US dollars
Employee benefit liabilities
2,969,000 US dollars
Additional paid-in capital
1,718,667,000 US dollars
Ordinary shares no par value, Unlimited shares authorized; issued and outstanding: 116,442,465 shares and 112,492,667 shares at June 30, 2026 (unaudited) and December 31, 2025, respectively
0 US dollars
Retained earnings (accumulated deficit)
negative 1,377,153,000 US dollars
Accumulated other comprehensive income (loss)
negative 3,422,000 US dollars
Gross equity (calculated)
1,718,667,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
NovoCure Limited (NVCR) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!